Chiara F. Sugrue, MBA, MS, SCT(ASCP)

More documents

Recommendations

Info

Propose a new CPT code for FNA ROSA performed by Cytotechnologists cont. • Accepting the reimbursement system as immutable is not in the profession best interest • Changes in AMA recommendation and C<strong>MS</strong> approval will require hard work • When Pathologists and Cytotechnologists work as team better outcome better patient care • As professional organization, we should become the agent of change. 22
New model for FNA rapid on‐site Assessment of Adequacy by Cytotechnologists • Brings the lab to the patient • Adds value to the lab Holistic pursuit • Maintains lab presence in the patient‐centered team • Creates an institutional logic THANK YOU 23
Page 1 and 2: CHIARA SUGRUE, MBA, MS, SCT(ASCP)CM
Page 3 and 4: EXTENDED ROLE OF CYTOTECHNOLOGISTS
Page 5 and 6: FNA Rapid On‐Site Assessment of A
Page 7 and 8: FNA Rapid Onsite Assessment of Adeq
Page 9 and 10: FNA TEAM @ NSLIJHS Laboratories Fro
Page 11 and 12: FNA Rapid On‐Site Assessment of A
Page 13 and 14: Lab productivity loss: example Spec
Page 15 and 16: DISADVANTAGE: Inadequate service co
Page 17 and 18: • New ways to apply technology
Page 19 and 20: Telepathology validation at NSLIJHS
Page 21: Option 3: Propose a new CPT code fo

Chiara F. Sugrue, MBA, MS, SCT(ASCP)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?